A detailed history of Radnor Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Radnor Capital Management, LLC holds 18,540 shares of ABT stock, worth $1.9 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
18,540
Previous 20,296 8.65%
Holding current value
$1.9 Million
Previous $2.23 Million 5.68%
% of portfolio
0.36%
Previous 0.42%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$109.52 - $120.96 $192,317 - $212,405
-1,756 Reduced 8.65%
18,540 $2.11 Million
Q4 2023

Jan 11, 2024

BUY
$90.19 - $110.4 $69,716 - $85,339
773 Added 3.96%
20,296 $2.23 Million
Q3 2023

Oct 12, 2023

BUY
$95.53 - $114.62 $1.87 Million - $2.24 Million
19,523 New
19,523 $1.89 Million
Q1 2023

Apr 06, 2023

BUY
$96.86 - $114.01 $183,065 - $215,478
1,890 Added 11.47%
18,361 $1.86 Million
Q3 2022

Oct 12, 2022

BUY
$96.76 - $112.03 $31,543 - $36,521
326 Added 2.02%
16,471 $1.59 Million
Q2 2022

Jul 11, 2022

BUY
$102.07 - $123.37 $111,256 - $134,473
1,090 Added 7.24%
16,145 $1.75 Million
Q1 2022

Apr 25, 2022

BUY
$114.02 - $139.04 $343,998 - $419,483
3,017 Added 25.06%
15,055 $1.78 Million
Q4 2021

Jan 20, 2022

BUY
$115.53 - $141.46 $1.39 Million - $1.7 Million
12,038 New
12,038 $1.69 Million
Q3 2021

Oct 26, 2021

SELL
$116.66 - $129.06 $921,147 - $1.02 Million
-7,896 Closed
0 $0
Q4 2020

Jan 13, 2021

BUY
$105.0 - $114.42 $118,125 - $128,722
1,125 Added 16.61%
7,896 $865,000
Q3 2020

Nov 02, 2020

BUY
$91.64 - $111.29 $299,204 - $363,361
3,265 Added 93.13%
6,771 $737,000
Q2 2020

Jul 28, 2020

BUY
$76.57 - $98.0 $33,767 - $43,218
441 Added 14.39%
3,506 $321,000
Q3 2019

Oct 07, 2019

SELL
$81.84 - $88.74 $18,414 - $19,966
-225 Reduced 6.84%
3,065 $256,000
Q2 2019

Jul 18, 2019

BUY
$72.88 - $85.0 $239,775 - $279,650
3,290 New
3,290 $277,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.